Moreover, decreased Bcl‐2 and increased Bax and cleaved caspase‐3 were noted in tumour tissues from mice treated with Erlotinib, and these effects of Erlotinib were abrogated by the injection of HCC827R‐CSC‐EVs (all p < .01). This evidence concerns the gene BCL2 and neoplasm.